TuHURA Biosciences Inc (HURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $88.58M
Last updated: Nov 17, 2026 at 11:06 AM ET
TuHURA Biosciences Inc (HURA) Competitors
The companies most similar to TuHURA Biosciences are Zura Bio Limited Class A Ordinary Shares (ZURA), Coherus BioSciences (CHRS) and Humacyte (HUMA). By market cap, TuHURA Biosciences ranks 5th of the 13 companies on this page; Humacyte (HUMA) is the largest at $155.12M.
Peer Comparison
HURA's ROIC of -81.8% is below the peer median of -60.5%, and its revenue growth of 0.0% is in line with the median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| TuHURA Biosciences (HURA) | $88.58M | N/A | N/A | 0.0% | -81.8% | 0.0% | 0.00% |
| Zura Bio Limited Class A Ordinary Shares (ZURA) | $119.44M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| Humacyte Inc (HUMA) | $155.12M | N/A | 62.6x | 0.0% | -60.5% | 36.5% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immunic Inc (IMUX) | $102.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | $141.66M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Rallybio Corp (RLYB) | $88.03M | N/A | 203.1x | 6177.0% | N/A | 0.0% | 0.00% |
| XBiotech Inc (XBIT) | $59.76M | N/A | N/A | 0.0% | N/A | -93.3% | 0.00% |
| MAIA Biotechnology Inc. (MAIA) | $61.75M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $80.40M | N/A | 32.1x | 0.0% | -60.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to TuHURA Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Zura Bio Limited Class A Ordinary Shares (ZURA) | Zura Bio Limited (Ticker: ZURA) is a biotechnology firm dedicated to developing breakthrough therapies for autoimmune disorders and rare diseases. | ZURA competitors |
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| Humacyte Inc (HUMA) | Humacyte Inc (HUMA) is a groundbreaking biotechnology firm at the forefront of vascular and regenerative medicine... | HUMA competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Immunic Inc (IMUX) | Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune... | IMUX competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| NeOnc Technologies Holdings, Inc. Common Stock (NTHI) | NeOnc Technologies Holdings, Inc. is a pioneering biotechnology firm dedicated to revolutionizing cancer treatment through its advanced immunotherapy... | NTHI competitors |
| Rallybio Corp (RLYB) | Rallybio Corp is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases... | RLYB competitors |
| XBiotech Inc (XBIT) | XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases. | XBIT competitors |
| MAIA Biotechnology Inc. (MAIA) | MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes... | MAIA competitors |
Frequently Asked Questions About HURA
Who are TuHURA Biosciences' main competitors?
The companies most similar to TuHURA Biosciences include Zura Bio Limited Class A Ordinary Shares (ZURA), Coherus BioSciences (CHRS), Humacyte (HUMA), vTv Therapeutics (VTVT) and Tenaya Therapeutics (TNYA), listed from the closest match.
Who is TuHURA Biosciences' biggest competitor?
Humacyte (HUMA) is the largest of the similar companies at $155.12M; Zura Bio Limited Class A Ordinary Shares (ZURA) is the closest match by business profile, size, sector and industry.
How does HURA stock compare with its competitors?
HURA's net margin is 0.0% against a peer median of 0.0%.
Which of TuHURA Biosciences' competitors pays a higher dividend?
TuHURA Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is TuHURA Biosciences bigger than its competitors?
No. TuHURA Biosciences is 5th by market cap among the 13 companies on this page; the largest is Humacyte (HUMA) at $155.12M.
HURA pages: Overview, Earnings, Forecast, Financials, Competitors